Revenue Growth

Paris – October 13, 2026 -- Ekinops reported Q3 2026 revenue of €31.9m, up 43% on Q3 2025 (+42% at constant scope and exchange rates) and up 4% sequentially from Q2 2026, and raised its full-year growth target to high single digits.

Nine-month sales reach €90.1m, up 13%

Revenue for the first nine months of 2026 totaled €90.1m, up 13% year on year (+11% at constant scope and exchange rates). Olfeo, consolidated since June 1, 2025, contributed €1.8m to Q3 revenue. Chimere, consolidated since April 1, 2026, made a non-material contribution, as expected.

Toronto – October 12, 2026 -- Profound Medical Corp. expects third-quarter 2026 revenue of $9.8 million to $10.0 million, roughly 45% to 47% above the Bloomberg mean analyst consensus of $6.78 million.

Revenue nearly doubles year over year and almost quadruples sequentially

The preliminary, unaudited range implies growth of approximately 85% to 89% from $5.3 million in the third quarter of 2025. Compared with $2.5 million in the second quarter of 2026, revenue is expected to rise approximately 292% to 300%.

The Nasdaq- and TSX-listed company expects gross margin to exceed 70% for the quarter, again above that threshold. Profound attributes the margin to progress in its commercial operations and scale.

Aspen, Colo. – – October 08, 2026 -- 21X has appointed Adam Squire as president of 21X SPORTS, a new revenue platform targeting leagues, professional and minor league teams, collegiate athletic departments, and sports apparel companies seeking incremental revenue from existing fan relationships.

Squire brings a decade of sports industry operating experience to the new role

Squire joined CapStone Holdings in 2022 and currently leads sports operations for GameAbove Sports, managing professional athlete relationships and sports partnerships. His background spans collegiate athletics, golf technology and equipment investments, youth development initiatives, and signature events.